Peter J Graham - Net Worth and Insider Trading

Peter J Graham Net Worth

The estimated net worth of Peter J Graham is at least $4 Million dollars as of 2024-11-05. Peter J Graham is the EVP General Counsel, Secretary of Antares Pharma Inc and owns about 540,417 shares of Antares Pharma Inc (ATRS) stock worth over $3 Million. Peter J Graham is also the Director of AngioDynamics Inc and owns about 92,466 shares of AngioDynamics Inc (ANGO) stock worth over $649,574. Details can be seen in Peter J Graham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter J Graham has not made any transactions after 2021-02-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Peter J Graham

To

Peter J Graham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter J Graham owns 3 companies in total, including Antares Pharma Inc (ATRS) , Delcath Systems Inc (DCTH) , and AngioDynamics Inc (ANGO) .

Click here to see the complete history of Peter J Graham’s form 4 insider trades.

Insider Ownership Summary of Peter J Graham

Ticker Comapny Transaction Date Type of Owner
ATRS Antares Pharma Inc 2022-05-24 See Remarks
DCTH Delcath Systems Inc 2010-04-20 EVP; General Counsel
ANGO AngioDynamics Inc 2006-01-16 director

Peter J Graham Latest Holdings Summary

Peter J Graham currently owns a total of 2 stocks. Among these stocks, Peter J Graham owns 540,417 shares of Antares Pharma Inc (ATRS) as of February 18, 2021, with a value of $3 Million and a weighting of 82.3%. Peter J Graham also owns 92,466 shares of AngioDynamics Inc (ANGO) as of January 16, 2006, with a value of $649,574 and a weighting of 17.7%.

Latest Holdings of Peter J Graham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRS Antares Pharma Inc 2021-02-18 540,417 5.59 3,020,931
ANGO AngioDynamics Inc 2006-01-16 92,466 7.03 649,574

Holding Weightings of Peter J Graham


Peter J Graham Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter J Graham has made a total of 1 transactions in Antares Pharma Inc (ATRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Antares Pharma Inc is the sale of 45,000 shares on February 18, 2021, which brought Peter J Graham around $221,850.

According to the SEC Form 4 filings, Peter J Graham has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the sale of 0 shares on January 16, 2006, which brought Peter J Graham around $0.

Insider Trading History of Peter J Graham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter J Graham Trading Performance

GuruFocus tracks the stock performance after each of Peter J Graham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Graham is 28.75%. GuruFocus also compares Peter J Graham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Graham within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter J Graham's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter J Graham

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Peter J Graham Ownership Network

Ownership Network List of Peter J Graham

No Data

Ownership Network Relation of Peter J Graham

Insider Network Chart

Peter J Graham Owned Company Details

What does Antares Pharma Inc do?

Who are the key executives at Antares Pharma Inc?

Peter J Graham is the See Remarks of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and director & President & CEO Robert F Apple .

Antares Pharma Inc (ATRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Antares Pharma Inc Insider Transactions

No Available Data

Peter J Graham Mailing Address

Above is the net worth, insider trading, and ownership report for Peter J Graham. You might contact Peter J Graham via mailing address: 315 E. 72nd St., Apt 5e, New York Ny 10021.